Pardes Biosciences, Inc. Stock
Equities
PRDS
US69945Q1058
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 18 M€ | +3.28% | - |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |